Australian medicinal cannabis prescriptions far exceed tested THC levels, Monash review finds

Australian medicinal cannabis prescriptions far exceed tested THC levels, Monash review finds

A Monash University review found Australian doctors prescribe medicinal cannabis at THC concentrations up to 88%, while clinical trial evidence only covers up to 22%. No safety data exists beyond that threshold, and Australia sets no upper THC limit. Of over 1,000 products available, only two passed TGA pre-market evaluation. The TGA has designated medicinal cannabis a 2026 priority area.

Published

Read at another depth